Elysian BioScience was established with the needs of patients and healthcare providers in mind. In today’s face-paced society, coupled with a population who are living longer, natural alternatives to the management of acute and chronic conditions are of critical importance. We believe that the answer lies within the cannabidiol (CBD) market. Its benefits have seen a marked increase in adoption since the passing of the Farm Bill in 2018.
While many patients are experiencing the beneficial properties of the hemp plant for many common ailments, Elysian found that there were many questions among patients and the medical community about CBD, its benefits and how it provides relief. Our goal is to the education of healthcare professionals and patients regarding the pharmacological and therapeutic options associated with CBD supported by clinical insights.
Elysian also understands the need for standardizing the production process and ensuring that CBD based products are manufactured at the same exacting standards required for pharmaceutical products. For this reason, Elysian is engaged in the entire process of development, manufacturing, marketing and distribution of plant-based CBD products. We are committed to providing a quality product that instills confidence for the healthcare professional and patient.

Elysian BioScience

Org chart

Teams

Offices